Fixed duration multidrug therapy (12 months) in leprosy patients with high bacillary load - Need to look beyond
Indian J Dermatol Venereol Leprol
.
2023;90(1):64-67.
doi: 10.25259/IJDVL_278_2023.
Authors
Tarun Narang
1
,
Joel G Almeida
2
,
Bhushan Kumar
3
,
P Narasimha Rao
4
,
Sujai Suneetha
5
,
Marco Andrey Cipriani Frade
6
,
Claudio Guedes Salgado
7
,
Sunil Dogra
1
Affiliations
1
Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
2
Public Health and Epidemiology, Public Health Consultancy, Mumbai, India.
3
Department of Dermatology, Silver Oaks Hospital, SAS Nagar, Punjab, India.
4
Department of Dermatology, Bhaskar Medical College, Telangana, Hyderabad, India.
5
Institute for Specialized Services in Leprosy (INSSIL), Nireekshana, Hyderabad, India.
6
Department of Medical Clinics, Dermatology Division, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
7
Laboratório de Dermato-Imunologia, Universidade Federal do Pará, Marituba, Pará, Brazil.
PMID:
37609736
DOI:
10.25259/IJDVL_278_2023
No abstract available
MeSH terms
Bacillus*
Drug Therapy, Combination
Humans
Leprostatic Agents / therapeutic use
Leprosy* / diagnosis
Leprosy* / drug therapy
Mycobacterium leprae
Substances
Leprostatic Agents